Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas.
D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism*; D001665:Binding Sites / Q000187:drug effects; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000502:physiology*; D006220:Haloperidol / Q000378:metabolism; D066298:In Vitro Techniques; D008032:Limbic System / Q000378:metabolism*; D009714:Nucleus Accumbens / Q000378:metabolism; D009830:Olfactory Bulb / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000502:physiology*; D013134:Spiperone / Q000378:metabolism
D014150:Antipsychotic Agents; D012701:Serotonin; D013134:Spiperone; D006220:Haloperidol; D004298:Dopamine